NZ503417A - Use of SAG (sensitive to apoptosis gene) in protecting cells from apoptosis - Google Patents
Use of SAG (sensitive to apoptosis gene) in protecting cells from apoptosisInfo
- Publication number
- NZ503417A NZ503417A NZ503417A NZ50341798A NZ503417A NZ 503417 A NZ503417 A NZ 503417A NZ 503417 A NZ503417 A NZ 503417A NZ 50341798 A NZ50341798 A NZ 50341798A NZ 503417 A NZ503417 A NZ 503417A
- Authority
- NZ
- New Zealand
- Prior art keywords
- sag
- apoptosis
- protein
- sensitive
- human
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4747—Apoptosis related proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6817997P | 1997-12-19 | 1997-12-19 | |
US9984098P | 1998-09-11 | 1998-09-11 | |
PCT/US1998/026705 WO1999032514A2 (fr) | 1997-12-19 | 1998-12-15 | Sag: gene sensible a l'apoptose |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ503417A true NZ503417A (en) | 2002-12-20 |
Family
ID=26748669
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ503417A NZ503417A (en) | 1997-12-19 | 1998-12-15 | Use of SAG (sensitive to apoptosis gene) in protecting cells from apoptosis |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1044217A2 (fr) |
JP (1) | JP2001526063A (fr) |
KR (1) | KR20010033299A (fr) |
AU (1) | AU765741B2 (fr) |
BR (1) | BR9813757A (fr) |
CA (1) | CA2303483A1 (fr) |
NZ (1) | NZ503417A (fr) |
WO (1) | WO1999032514A2 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7078203B1 (en) | 1999-03-31 | 2006-07-18 | The University Of North Carolina At Chapel Hill | Isolated DNA encoding cullin regulators ROC1 and ROC2, isolated proteins encoded by the same, and methods utilizing the same |
WO2000058472A2 (fr) * | 1999-03-31 | 2000-10-05 | The University Of North Carolina At Chapel Hill | Adn isole codant pour des regulateurs cullin roc1 et roc2, proteines isolees codees par ledit adn. procedes d'utilisation associes |
WO2001046468A2 (fr) * | 1999-12-21 | 2001-06-28 | Eirx Therapeutics Ltd | Technique de recherche |
US6740495B1 (en) | 2000-04-03 | 2004-05-25 | Rigel Pharmaceuticals, Inc. | Ubiquitin ligase assay |
US6979551B2 (en) | 2000-04-03 | 2005-12-27 | Rigel Pharmaceuticals, Inc. | Assays for identifying ubiquitin agents and for identifying agents that modify the activity of ubiquitin agents |
EP1299558B1 (fr) * | 2000-07-07 | 2006-05-10 | Eirx Therapeutics Ltd | Procede de criblage |
IL156557A0 (en) * | 2000-12-22 | 2004-01-04 | Janssen Pharmaceutica Nv | Bax-responsive genes for drug target identification in yeast and fungi |
CN115345122B (zh) * | 2022-08-31 | 2023-03-17 | 沐曦科技(北京)有限公司 | 一种用于仿真的非标准总线协议的芯片验证装置 |
-
1998
- 1998-12-15 KR KR1020007006741A patent/KR20010033299A/ko not_active Application Discontinuation
- 1998-12-15 JP JP2000525451A patent/JP2001526063A/ja active Pending
- 1998-12-15 CA CA002303483A patent/CA2303483A1/fr not_active Abandoned
- 1998-12-15 EP EP98963962A patent/EP1044217A2/fr not_active Withdrawn
- 1998-12-15 AU AU19180/99A patent/AU765741B2/en not_active Expired - Fee Related
- 1998-12-15 WO PCT/US1998/026705 patent/WO1999032514A2/fr not_active Application Discontinuation
- 1998-12-15 NZ NZ503417A patent/NZ503417A/xx unknown
- 1998-12-15 BR BR9813757-3A patent/BR9813757A/pt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP2001526063A (ja) | 2001-12-18 |
CA2303483A1 (fr) | 1999-07-01 |
KR20010033299A (ko) | 2001-04-25 |
EP1044217A2 (fr) | 2000-10-18 |
BR9813757A (pt) | 2000-10-03 |
WO1999032514A3 (fr) | 1999-09-10 |
WO1999032514A2 (fr) | 1999-07-01 |
AU1918099A (en) | 1999-07-12 |
AU765741B2 (en) | 2003-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Macmillan-Crow et al. | Manganese superoxide dismutase in disease | |
Wong et al. | Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor | |
Nehlin et al. | Yeast MIG1 repressor is related to the mammalian early growth response and Wilms' tumour finger proteins. | |
Unoki et al. | Novel splice variants of ING4 and their possible roles in the regulation of cell growth and motility | |
Kulmburg et al. | Specific binding sites in the alcR and alcA promoters of the ethanol regulon for the CREA repressor mediating carbon cataboiite repression in Aspergillus nidulans | |
Underhill-Day et al. | N-terminal rassf family: Rassf7-rassf10 | |
Fritz et al. | APE/Ref-1 and the mammalian response to genotoxic stress | |
Bhawe et al. | Interplay between NRF1, E2F4 and MYC transcription factors regulating common target genes contributes to cancer development and progression | |
Hou et al. | Ubiquitin-specific protease 4 promotes TNF-α-induced apoptosis by deubiquitination of RIP1 in head and neck squamous cell carcinoma | |
St. Clair et al. | Overproduction of human Mn‐superoxide dismutase modulates paraquat‐mediated toxicity in mammalian cells | |
Yan et al. | Proteomics characterization of gastrokine 1‐induced growth inhibition of gastric cancer cells | |
Feussner et al. | Isolation of a cDNA coding for an ubiquitin-conjugating enzyme UBC1 of tomato—the first stress-induced UBC of higher plants | |
Nouman et al. | The role of the tumour suppressor p33ING1b in human neoplasia | |
NZ503417A (en) | Use of SAG (sensitive to apoptosis gene) in protecting cells from apoptosis | |
Banerjee et al. | A novel role of gap junction connexin46 protein to protect breast tumors from hypoxia | |
US8735342B2 (en) | Method for treating brain cancer using a novel tumor suppressor gene and secreted factor | |
Chen et al. | CDC73 gene mutations in sporadic ossifying fibroma of the jaws | |
Bhaduri et al. | Rise of TRIM8: a molecule of duality | |
Liu et al. | Molecular cloning and characterization of human Castor, a novel human gene upregulated during cell differentiation | |
Bataille | Melanoma. Shall we move away from the sun and focus more on embryogenesis, body weight and longevity? | |
WO2001079556A3 (fr) | Nouveaux genes, compositions et methodes destines a l'identification, l'evaluation, la prevention, et la therapie de cancers humains | |
Zhou et al. | Identification and characterization of the novel protein CCDC106 that interacts with p53 and promotes its degradation | |
Ichikawa et al. | Novel PRMT5-mediated arginine methylations of HSP90A are essential for maintenance of HSP90A function in NDRG2low ATL and various cancer cells | |
Halachmi et al. | Update on genetic events in the pathogenesis of melanoma | |
He et al. | Identification of Aurora-A as a direct target of E2F3 during G2/M cell cycle progression |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RENW | Renewal (renewal fees accepted) | ||
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) |